A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.
Michael Thomas SchweizerKathleen HaugkJožefa S McKiernanRoman GulatiHeather H ChengJessica L MaesRuth F DumpitPeter S NelsonBruce MontgomeryJeannine S McCuneStephen R PlymateEvan Y YuPublished in: PloS one (2018)
Clinicaltrials.gov: NCT02532114.
Keyphrases